ATLANTA–(BUSINESS WIRE)–Silicon Creations, a leading provider of high-performance analog and mixed-signal IP today announced the successful…
Categoría: Business Wire
Categoría agregada por el Plugin WPeMatico
EDITED Announces Release of 2025 Black Friday Retail Analysis for US and UK Markets
A data-driven look at the trends shaping the biggest shopping weekend of the year, powered by…
North American Sustainable Refrigeration Council Launches F-gas Reduction Incentive Program’s Workforce Development Initiative
The program aims to address California’s shortage of qualified refrigeration technicians. MILL VALLEY, Calif,–(BUSINESS WIRE)–#GoNatRefs–The North…
SmartMoving Named to Inc.’s 2025 Best in Business List for Innovation
DALLAS–(BUSINESS WIRE)–SmartMoving, the leading profitability platform for moving companies, has been named to Inc. Magazine’s 2025…
BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BTDR—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a…
BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BTDR—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a…
CHS Owners Elect Five Directors to CHS Board
SAINT PAUL, Minn.–(BUSINESS WIRE)–Owners of CHS, a global agribusiness and the nation’s leading cooperative, elected five…
Aleta Biotherapeutics and Cancer Research UK Announce Promising Phase I/II Data from ALETA-001 Clinical Trial for Patients With Relapsed/Refractory B-Cell Malignancies Previously Treated with CD19 CAR T-Cell Therapy
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of…
Aleta Biotherapeutics and Cancer Research UK Announce Promising Phase I/II Data from ALETA-001 Clinical Trial for Patients With Relapsed/Refractory B-Cell Malignancies Previously Treated with CD19 CAR T-Cell Therapy
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of…
CHS Owners Elect Five Directors to CHS Board
SAINT PAUL, Minn.–(BUSINESS WIRE)–Owners of CHS, a global agribusiness and the nation’s leading cooperative, elected five…